• Sci2sci raised EUR 1.2 million in a pre-seed round co-led by IBB Capital GmbH, with Heliad.
• Berlin-based startup builds a neurosymbolic memory layer to make AI outputs traceable for regulated industries, starting with biopharma.
• Funding will expand engineering, accelerate deployments of Integrity Cortex, extend rollout of VectorCat across regulated enterprise workflows.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IBB Capital GmbH published the original content used to generate this news brief on September 08, 2026, and is solely responsible for the information contained therein.